{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:08:19Z","timestamp":1790525299825,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"KNMP"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11096-017-0575-7","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T08:59:10Z","timestamp":1512464350000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Patient-reported common symptoms as an assessment of interventions in medication reviews: a randomised, controlled trial"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0746-9445","authenticated-orcid":false,"given":"Tim W. A.","family":"Schoenmakers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. G. M.","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Teichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"issue":"17","key":"575_CR1","first-page":"1890","volume":"168","author":"AJ Leendertse","year":"2008","unstructured":"Leendertse AJ, Egberts ACG, Stoker LJ, Van Den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890\u20136.","journal-title":"Arch Intern Med"},{"issue":"4","key":"575_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pds.1565","volume":"17","author":"CS Hooft Van Der","year":"2008","unstructured":"Van Der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJ, Verhamme KM, Stricker BH, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2008;17(4):365\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"575_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","volume":"63","author":"RL Howard","year":"2007","unstructured":"Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136\u201347.","journal-title":"Br J Clin Pharmacol"},{"issue":"7456","key":"575_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15\u20139.","journal-title":"BMJ"},{"issue":"8","key":"575_CR5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00002018-200730080-00003","volume":"30","author":"BA Golomb","year":"2007","unstructured":"Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007;30(8):669\u201375.","journal-title":"Drug Saf"},{"issue":"5","key":"575_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2125.2009.03400.x","volume":"67","author":"F Hunsel Van","year":"2009","unstructured":"Van Hunsel F, Passier A, Van Grootheest K. Comparing patients\u2019 and healthcare professionals\u2019 ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol. 2009;67(5):558\u201364.","journal-title":"Br J Clin Pharmacol"},{"issue":"23","key":"575_CR7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","volume":"101","author":"E Basch","year":"2009","unstructured":"Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624\u201332.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"575_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejim.2012.01.004","volume":"23","author":"S Sathasivam","year":"2012","unstructured":"Sathasivam S. Statin induced myotoxicity. Eur J Intern Med. 2012;23(4):317\u201324.","journal-title":"Eur J Intern Med"},{"issue":"12","key":"575_CR9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2165\/11593810-000000000-00000","volume":"34","author":"L Hakobyan","year":"2011","unstructured":"Hakobyan L, Haaijer-Ruskamp FM, de Zeeuw D, Dobre D, Denig P. Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post hoc analysis of observational studies published between 1999 and 2011. Drug Saf. 2011;34(12):1191\u2013202.","journal-title":"Drug Saf"},{"key":"575_CR10","unstructured":"Pharmaceutical Care Network Europe. Position Paper on the PCNE definition of Medication Review 2016. 2016. http:\/\/www.pcne.org\/upload\/files\/149_Position_Paper_on_PCNE_Medication_Review_final.pdf . Accessed 27 Oct 2017."},{"issue":"4","key":"575_CR11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2012.04331.x","volume":"74","author":"A Blenkinsopp","year":"2012","unstructured":"Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573\u201380.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"575_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2012.04178.x","volume":"74","author":"MME Geurts","year":"2012","unstructured":"Geurts MME, Talsma J, Brouwers JRBJ, de Gier JJ. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012;74(1):16\u201333.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"575_CR13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bcp.12140","volume":"77","author":"E Hatah","year":"2014","unstructured":"Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77(1):102\u201315.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"575_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sapharm.2016.08.005","volume":"13","author":"N Jokanovic","year":"2017","unstructured":"Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661\u201385.","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"575_CR15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bcp.13197","volume":"83","author":"JB Beuscart","year":"2017","unstructured":"Beuscart JB, Pont LG, Thevelin S, Boland B, Dalleur O, Rutjes AW, et al. A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set. Br J Clin Pharmacol. 2017;83(5):942\u201352.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"575_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ageing\/30.3.205","volume":"30","author":"J Krska","year":"2001","unstructured":"Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205\u201311.","journal-title":"Age Ageing"},{"issue":"6","key":"575_CR17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2125.2004.02220.x","volume":"58","author":"L Sorensen","year":"2004","unstructured":"Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648\u201364.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"575_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-144-4-200602210-00007","volume":"144","author":"S Bent","year":"2006","unstructured":"Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med. 2006;144(4):257\u201361.","journal-title":"Ann Intern Med"},{"issue":"2","key":"575_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jama.2013.6855","volume":"310","author":"E Basch","year":"2013","unstructured":"Basch E, Torda P, Adams K. Standards for patient-reported outcome-based performance measures. JAMA. 2013;310(2):139\u201340.","journal-title":"JAMA"},{"issue":"5","key":"575_CR20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2753.2006.00650.x","volume":"12","author":"S Marshall","year":"2006","unstructured":"Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: a structured review. J Eval Clin Pract. 2006;12(5):559\u201368.","journal-title":"J Eval Clin Pract"},{"issue":"1\u20133","key":"575_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pec.2007.08.011","volume":"69","author":"A-C M\u00e5rdby","year":"2007","unstructured":"M\u00e5rdby A-C, Akerlind I, J\u00f6rgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69(1\u20133):158\u201364.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"575_CR22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40264-017-0504-7","volume":"40","author":"TW Schoenmakers","year":"2017","unstructured":"Schoenmakers TW, Teichert M, Wensing M, de Smet PA. Evaluation of potentially drug-related patient-reported common symptoms assessed during clinical medication reviews: a cross-sectional observational study. Drug Saf. 2017;40(5):419\u201330.","journal-title":"Drug Saf"},{"key":"575_CR23","unstructured":"Dutch General Practitioners, Dutch Geriatric Society, Dutch Order of Medical Specialists. Multidisciplinary guideline polypharmacy in the elderly. Nederlands Huisartsen Genootschap, Utrecht. 2012. https:\/\/www.nhg.org\/sites\/default\/files\/content\/nhg_org\/uploads\/polyfarmacie_bij_ouderen.pdf . Accessed 4 Apr 2014."},{"key":"575_CR24","unstructured":"Royal Dutch Pharmacists Association (KNMP). Richtlijn Medicatiebeoordeling. KNMP, The Hague. 2013. https:\/\/www.knmp.nl\/patientenzorg\/medicatiebewaking\/medicatiebeoordeling\/knmp-richtlijn-medicatiebeoordeling . Accessed 27 June 2013."},{"issue":"27","key":"575_CR25","first-page":"11","volume":"151","author":"SFK","year":"2016","unstructured":"SFK. Sterke toename aantal polyfarmaciepati\u00ebnten. Pharm Weekbl. 2016;151(27):11.","journal-title":"Pharm Weekbl"},{"key":"575_CR26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/1471-2458-13-320","volume":"13","author":"S Wu","year":"2013","unstructured":"Wu S, Wang R, Zhao Y, Ma X, Wu M, Yan X, et al. The relationship between self-rated health and objective health status: a population-based study. BMC Public Health. 2013;13:320.","journal-title":"BMC Public Health"},{"key":"575_CR27","unstructured":"RIVM. Wat is ervaren gezondheid en hoe wordt het gemeten? In: Nationaal Kompas Volksgezondheid. Rijksinstituut voor Volksgezondheid en Milieuhygiene (RIVM), Bilthoven. 2014. https:\/\/www.volksgezondheidenzorg.info\/onderwerp\/ervaren-gezondheid\/regionaal-internationaal\/internationaal#bronverantwoording . Accessed 16 Dec 2016."},{"issue":"1","key":"575_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1\u201324.","journal-title":"Psychol Health"},{"issue":"3","key":"575_CR29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pec.2010.06.029","volume":"80","author":"KA Cameron","year":"2010","unstructured":"Cameron KA, Ross EL, Clayman ML, Bergeron AR, Federman AD, Bailey SC, et al. Measuring patients\u2019 self-efficacy in understanding and using prescription medication. Patient Educ Couns. 2010;80(3):372\u20136.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"575_CR30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ageing\/aft083","volume":"42","author":"HF Kwint","year":"2013","unstructured":"Kwint HF, Stolk G, Faber A, Gussekloo J, Bouvy ML. Medication adherence and knowledge of older patients with and without multidose drug dispensing. Age Ageing. 2013;42(5):620\u20136.","journal-title":"Age Ageing"},{"issue":"4","key":"575_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1742395310369018","volume":"6","author":"R Horne","year":"2010","unstructured":"Horne R, Clatworthy J, Hankins M. High adherence and concordance within a clinical trial of antihypertensives. Chronic Illn. 2010;6(4):243\u201351.","journal-title":"Chronic Illn"},{"issue":"1","key":"575_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08870440290001502","volume":"17","author":"R Horne","year":"2002","unstructured":"Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17\u201332.","journal-title":"Psychol Health"},{"issue":"6","key":"575_CR33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40266-015-0270-0","volume":"32","author":"MC Meulendijk","year":"2015","unstructured":"Meulendijk MC, Spruit MR, Drenth-van Maanen AC, Numans ME, Brinkkemper S, Jansen PAF, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP assistant\u2019s usability. Drugs Aging. 2015;32(6):495\u2013503.","journal-title":"Drugs Aging"},{"key":"575_CR34","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC Classifications System 2013. World Health Organization, Oslo. 2013. http:\/\/www.whocc.no\/atc_ddd_index\/ Accessed 22 Sept 2014."},{"issue":"10","key":"575_CR35","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3899\/jrheum.081204","volume":"36","author":"BJ Bemt van den","year":"2009","unstructured":"van den Bemt BJ, van den Hoogen FH, Benraad B, Hekster YA, van Riel PL, van Lankveld W. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009;36(10):2164\u201370.","journal-title":"J Rheumatol"},{"issue":"4","key":"575_CR36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s11096-016-0301-x","volume":"38","author":"M Teichert","year":"2016","unstructured":"Teichert M, Schoenmakers T, Kylstra N, Mosk B, Bouvy ML, van de Vaart F, et al. Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies. Int J Clin Pharm. 2016;38(4):870\u20139.","journal-title":"Int J Clin Pharm"},{"key":"575_CR37","unstructured":"Royal Dutch Pharmacists Association (KNMP). KNMP Kennisbank. KNMP, The Hague. https:\/\/kennisbank.knmp.nl\/ . Accessed 10 July 2013."},{"issue":"1","key":"575_CR38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1345\/aph.1K073","volume":"42","author":"O Oladimeji","year":"2008","unstructured":"Oladimeji O, Farris KB, Urmie JG, Doucette WR. Risk factors for self-reported adverse drug events among Medicare enrollees. Ann Pharmacother. 2008;42(1):53\u201361.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"575_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMp1611252","volume":"376","author":"E Basch","year":"2017","unstructured":"Basch E. Patient-reported outcomes\u2014harnessing patients\u2019 voices to improve clinical care. N Engl J Med. 2017;376(2):105\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"575_CR40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11096-016-0258-9","volume":"38","author":"F Willeboordse","year":"2016","unstructured":"Willeboordse F, Grundeken LH, van den Eijkel LP, Schellevis FG, Elders PJ, Hugtenburg JG. Information on actual medication use and drug-related problems in older patients: questionnaire or interview? Int J Clin Pharm. 2016;38(2):380\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"575_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40266-012-0048-6","volume":"30","author":"HF Kwint","year":"2013","unstructured":"Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91\u2013102.","journal-title":"Drugs Aging"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-017-0575-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0575-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0575-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T08:48:47Z","timestamp":1570438127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-017-0575-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1007\/s11096-017-0575-7","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}